Vericel Corporation (VCEL) News
Follow Vericel Corporation (VCEL) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Vericel to present at Morgan Stanley Global Healthcare Conference on Sept. 15
Vericel Corporation (VCEL) will present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, Sept. 15, 2026.
EQUITY | Sep 08, 2026, 12:38 PM UTC
L
VCEL to present at Morgan Stanley Global Healthcare Conference
Vericel (VCEL) plans to present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026.
EQUITY | Sep 08, 2026, 12:30 PM UTC
L
Vericel Raises FY2026 Sales Guidance from $326.000M-$336.000M to $330.000M-$340.000M vs $332.199M Est
Vericel (NASDAQ: VCEL ) raises FY2026 sales outlook from $326.000 million-$336.000 million to $330.000 million-$340.000 million vs $332.199 million estimate.
EARNINGS | Jul 30, 2026, 11:55 AM UTC
H
VCEL authorizes $200M buyback
VCEL launches $200M share repurchase
EQUITY | Jul 30, 2026, 11:55 AM UTC
L
VCEL Vericel RESULTS: Q2, Q2 REV $77.457M vs. EST $72.7M, Q2 gross profit $56.402M, Q2 Net Income $2.206M, Q2 ADJ EBITDA $14.864M, Q2 gross
VCEL Vericel RESULTS: Q2, Q2 REV $77.457M vs. EST $72.7M, Q2 gross profit $56.402M, Q2 Net Income $2.206M, Q2 ADJ EBITDA $14.864M, Q2 gross margin 73%, Q2 EPS $0.04, Q2 ADJ EBITDA margin 19%
EARNINGS | Jul 30, 2026, 11:55 AM UTC
L
VCEL - Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program - C
VCEL - Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program
EARNINGS | Jul 30, 2026, 11:55 AM UTC